Search research articles
Contact Us
Filters
Showing results (531-540 of 778) with videos related to
Page
of 78
Sort By:
Circulation
|
January 5, 2000
Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women
M Roest, Y T van der Schouw, J D Banga, et al.
Thrombosis and Haemostasis
|
July 15, 1999
Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease
H Lankhof, C Damas, M E Schiphorst, et al.
Blood
|
August 15, 2002
Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2)
Rob J Dekker, Simone van Soest, Ruud D Fontijn, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 13, 2001
A novel method for isolating pure microvascular endothelial cells from subcutaneous fat tissue ideal for direct cell seeding
C H Arts, G J Heijnen-Snyder, P P Joosten, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 12, 2014
Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis
P P Wisman, M Roest, F W Asselbergs, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
November 5, 2004
[Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura]
J J Hulstein, C N Rison, M C Kappers-Klunne, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin
P A Steerenberg, C P Vendrik, W H de Jong, et al.
Experimental Cell Research
|
January 1, 1986
Reconstitution of the vascular wall in vitro. A novel model to study interactions between endothelial and smooth muscle cells
M F van Buul-Wortelboer, H J Brinkman, K P Dingemans, et al.
Gastroenterology
|
July 5, 2001
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis
T Lisman, F W Leebeek, L O Mosnier, et al.
Blood
|
September 23, 2008
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients
Augusto B Federici, Pier M Mannucci, Giancarlo Castaman, et al.
Page
of 78
Search research articles
Search
Showing results (531-540 of 778) with videos related to
Sort By:
Page
of 78
Circulation
|
January 5, 2000
Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women
M Roest, Y T van der Schouw, J D Banga, et al.
Thrombosis and Haemostasis
|
July 15, 1999
Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease
H Lankhof, C Damas, M E Schiphorst, et al.
Blood
|
August 15, 2002
Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2)
Rob J Dekker, Simone van Soest, Ruud D Fontijn, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 13, 2001
A novel method for isolating pure microvascular endothelial cells from subcutaneous fat tissue ideal for direct cell seeding
C H Arts, G J Heijnen-Snyder, P P Joosten, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 12, 2014
Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis
P P Wisman, M Roest, F W Asselbergs, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
November 5, 2004
[Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura]
J J Hulstein, C N Rison, M C Kappers-Klunne, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin
P A Steerenberg, C P Vendrik, W H de Jong, et al.
Experimental Cell Research
|
January 1, 1986
Reconstitution of the vascular wall in vitro. A novel model to study interactions between endothelial and smooth muscle cells
M F van Buul-Wortelboer, H J Brinkman, K P Dingemans, et al.
Gastroenterology
|
July 5, 2001
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis
T Lisman, F W Leebeek, L O Mosnier, et al.
Blood
|
September 23, 2008
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients
Augusto B Federici, Pier M Mannucci, Giancarlo Castaman, et al.
Page
of 78